Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Republic HealthcareHKSE:08357 30 EV-to-FCF is -4.81 as of Aug. 24, 2026. GuruFocus rates HKSE:08357 with a GF Score™ of 30/100 and a GF Value™ of HK$0.09 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 413 Healthcare Providers & Services companies, Republic Healthcare ranks worse than 242130.51% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Republic Healthcare's Enterprise Value is HK$52.05 Mil.
Republic Healthcare's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was HK$-10.83 Mil. Therefore, Republic Healthcare's EV-to-FCF for today is -4.81.
The historical rank and industry rank for Republic Healthcare's EV-to-FCF or its related term are showing as below:
HKSE:08357'
s EV-to-FCF Range Over the Past 10 Years
Min: -4346.25 Med: -3.94 Max: 199.79
Current: -4.81
During the past 10 years, the highest EV-to-FCF of Republic Healthcare was 199.79. The lowest was -4346.25. And the median was -3.94.
HKSE:08357's EV-to-FCF is ranked worse than 100% of 413
companies
in the Healthcare Providers & Services industry
Industry Median: 18.55
vs HKSE:08357: -4.81
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Republic Healthcare's PE Ratio (TTM) for today is calculated as:
Republic Healthcare's share price for today is HK$0.103.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Republic Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was HK$-0.032.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Republic Healthcare EV-to-FCF Related Terms
Republic Healthcare EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Republic Healthcare's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Republic Healthcare's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Republic Healthcare EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Republic Healthcare's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Republic Healthcare's EV-to-FCF falls into.
Republic Healthcare's current Enterprise Value is HK$52.05 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Republic Healthcare's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was HK$-10.83 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Republic Healthcare (HKSE:08357) has a EV-to-FCF of -4.81 as of Aug. 24, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Republic Healthcare and its competitors. According to the industry distribution chart, Republic Healthcare ranks #999999 out of 413 companies in the Healthcare Providers & Services industry.
Is Republic Healthcare's EV-to-FCF too high?
Republic Healthcare's current EV-to-FCF is -4.81. Based on the distribution chart, Republic Healthcare ranks #999999 out of 413 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Republic Healthcare has a GF Score™ of 30/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Republic Healthcare's EV-to-FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Republic Healthcare ranks #999999 out of 413 companies for EV-to-FCF. This places Republic Healthcare in the lower half of its industry. The industry median EV-to-FCF is 18.55. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 18.55, based on 413 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Republic Healthcare and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 18.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Republic Healthcare's current EV-to-FCF is -4.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Republic Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Republic Healthcare (HKSE:08357) is currently considered Modestly Overvalued. The stock's GF Value™ is HK$0.09, compared to a current price of HK$0.10 — trading 14.4% above its estimated fair value. The current EV-to-FCF is -4.81. Republic Healthcare's overall GF Score™ is 30/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Republic Healthcare (HKSE:08357), the current EV-to-FCF is -4.81 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Republic Healthcare (HKSE:08357) Overvalued in 2026?
Based on GuruFocus' analysis, Republic Healthcare stock appears to be overvalued.
The current stock price of HK$0.10 is trading 14.4% above its estimated GF Value™ of HK$0.09.
GuruFocus considers Republic Healthcare to be Modestly Overvalued.
Key valuation signals for HKSE:08357:
EV-to-FCF: -4.81
GF Value™: HK$0.09 vs. price of HK$0.10 (14.4% above fair value)
No single metric tells the full story. See the HKSE:08357 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Republic Healthcare Ltd is principally engaged in the clinic business in Singapore and the provision of management advisory services. The company provides healthcare services operating a network of general practice clinics, treatment solutions for common medical conditions with a focus on sexual health and infectious diseases, and operation of a medical aesthetics clinic that focuses on providing treatment solutions for common skin conditions and basic medical aesthetics services. The company is segments are medical services and education services. The Group is engaged in the operation of medical clinics and the provision of management advisory services, pepper trading business, and healthcare-related education business. It generates maximum revenue from Singapore.
30GF Score
Get the complete analysis for HKSE:08357
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08357 has been successfully added to your 
